Virginia Retirement Systems Et Al Cullinan Oncology, Inc. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 64,700 shares of CGEM stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
64,700
Previous 64,800
0.15%
Holding current value
$1.16 Million
Previous $697,000
16.07%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CGEM
# of Institutions
140Shares Held
65.9MCall Options Held
77.2KPut Options Held
15.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$137 Million21.42% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$103 Million3.07% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$63.7 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$61.2 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$58.8 Million1.2% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $818M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...